{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:21:07Z","timestamp":1791865267898,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lumbar puncture (LP) has become increasingly common for people with Huntington\u2019s disease (HD) both to administer intrathecal investigational medicinal products and to collect cerebrospinal fluid to develop biological markers to track disease stage and progression. We aimed to investigate the safety profile of LP in people with HD, building on a recently published work by increasing the sample size and more specifically, increasing the representation of the premanifest population and healthy controls. We conducted a multi-study cross-sectional analysis including eligible participants from the HDClarity (304 Huntington's disease gene expansion carriers and 91 controls) and HD-YAS studies (54 premanifest and 48 controls), enrolled between February 2016 and September 2019. We investigated the odds of any adverse events, headaches, and back pain independently. Intergroup comparisons and adjusted event odds were derived using hierarchical logistic regressions. A total of 669 LP procedures involving 497 participants were included in this analysis. There were 184 (27.5%) LP procedures associated with one or more adverse events. The two most common adverse events were: post LP headache and back pain. Younger age and female gender were found to be associated with a higher risk of developing adverse events. There was no difference in the rate of adverse events between the disease subgroups after adjusting for covariates such as age and gender. Our results suggest that the LP is safe and tolerable in premanifest and manifest HD subjects, providing useful reassurance about the procedure to the HD community.<\/jats:p>","DOI":"10.1038\/s41598-022-21934-6","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T11:03:06Z","timestamp":1667300586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lumbar puncture safety and tolerability in premanifest and manifest Huntington\u2019s disease: a multi-analysis cross-sectional study"],"prefix":"10.1038","volume":"12","author":[{"given":"Yara Refaat","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe","family":"Brogueira Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Zeun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Estevez-Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Tortelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael I.","family":"Scahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"21934_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald, M. E. et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72, 971\u2013983 (1993).","journal-title":"Cell"},{"key":"21934_CR2","first-page":"111","volume":"8","author":"S Engelborghs","year":"2017","unstructured":"Engelborghs, S. et al. Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit. 8, 111\u2013126 (2017).","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"21934_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.parkreldis.2018.12.025","volume":"62","author":"N Prakash","year":"2019","unstructured":"Prakash, N. et al. Feasibility and safety of lumbar puncture in the Parkinson\u2019s disease research participants: Parkinson\u2019s progression marker initiative (PPMI). Park. Relat. Disord. 62, 201\u2013209 (2019).","journal-title":"Park. Relat. Disord."},{"key":"21934_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jalz.2015.08.003","volume":"12","author":"FH Duits","year":"2016","unstructured":"Duits, F. H. et al. Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study. Alzheimer\u2019s Dement. 12, 154\u2013163 (2016).","journal-title":"Alzheimer\u2019s Dement."},{"key":"21934_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/2021.07.30.21261340","author":"FB Rodrigues","year":"2021","unstructured":"Rodrigues, F. B. et al. Safety and feasibility of research lumbar puncture in Huntington\u2019s disease: The HDClarity cohort and bioresource. medRxiv https:\/\/doi.org\/10.1101\/2021.07.30.21261340 (2021).","journal-title":"medRxiv"},{"key":"21934_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S1474-4422(20)30143-5","volume":"19","author":"RI Scahill","year":"2020","unstructured":"Scahill, R. I. et al. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington\u2019s disease young adult Study (HD-YAS): A cross-sectional analysis. Lancet Neurol. 19, 502\u2013512 (2020).","journal-title":"Lancet Neurol."},{"key":"21934_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/mdc3.12388","volume":"4","author":"GB Landwehrmeyer","year":"2017","unstructured":"Landwehrmeyer, G. B. et al. Data analytics from enroll-HD, a global clinical research platform for Huntington\u2019s disease. Mov. Disord. Clin. Pract. 4, 212\u2013224 (2017).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"21934_CR8","doi-asserted-by":"crossref","unstructured":"Trundell, D. et al. Defining Clinically Meaningful Change on the Composite Unified Huntington\u2019s Disease Rating Scale (cUHDRS). Neurology 92, P1.8\u2013043 (2019).","DOI":"10.1212\/WNL.92.15_supplement.P1.8-043"},{"key":"21934_CR9","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/mds.27653","volume":"34","author":"E Bruzelius","year":"2019","unstructured":"Bruzelius, E. et al. Huntington\u2019s disease in the United States: Variation by demographic and socioeconomic factors. Mov. Disord. 34, 858\u2013865 (2019).","journal-title":"Mov. Disord."},{"key":"21934_CR10","first-page":"1186","volume":"15","author":"M Gooding","year":"2018","unstructured":"Gooding, M. et al. Enrichment strategy in early-to-moderate manifest Huntington disease based on CAG\/Age product (CAP) > 400 threshold. Neurotherapeutics 15, 1186 (2018).","journal-title":"Neurotherapeutics"},{"key":"21934_CR11","doi-asserted-by":"publisher","unstructured":"Trundell, D. et al. F23 Validity, reliability, ability to detect change and meaningful within-patient change of the CUHDRS. A48.1-A48. https:\/\/doi.org\/10.1136\/jnnp-2018-ehdn.127(2018).","DOI":"10.1136\/jnnp-2018-ehdn.127"},{"key":"21934_CR12","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1212\/WNL.0000000000004743","volume":"89","author":"SA Schobel","year":"2017","unstructured":"Schobel, S. A. et al. Motor, cognitive, and functional declines contribute to a single progressive factor in early HD. Neurology 89, 2495 (2017).","journal-title":"Neurology"},{"key":"21934_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney","year":"1997","unstructured":"Penney, J. B., Vonsattel, J. P., MacDonald, M. E., Gusella, J. F. & Myers, R. H. CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann. Neurol. 41, 689\u2013692 (1997).","journal-title":"Ann. Neurol."},{"key":"21934_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ajmg.b.30992","volume":"153","author":"DR Langbehn","year":"2010","unstructured":"Langbehn, D. R. et al. CAG-repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153, 397\u2013408 (2010).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"21934_CR15","first-page":"814","volume":"0","author":"N Ghazaleh","year":"2021","unstructured":"Ghazaleh, N. et al. Ranking the predictive power of clinical and biological features associated with disease progression in Huntington\u2019s disease. Front Neurol. 0, 814 (2021).","journal-title":"Front Neurol."},{"key":"21934_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/ajmg.b.31232","volume":"156","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156, 751 (2011).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"21934_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1212\/WNL.0b013e3182840bf6","volume":"80","author":"WPJ van Oosterhout","year":"2013","unstructured":"van Oosterhout, W. P. J. et al. Postdural puncture headache in migraineurs and nonheadache subjects: A prospective study. Neurology 80, 941\u2013948 (2013).","journal-title":"Neurology"},{"key":"21934_CR18","doi-asserted-by":"crossref","unstructured":"Arevalo-Rodriguez, I. et al. Needle gauge and tip designs for preventing post-dural puncture headache (PDPH). Cochrane Database Syst. Rev. (2017).","DOI":"10.1002\/14651858.CD010807.pub2"},{"key":"21934_CR19","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J. et al. Targeting huntingtin expression in patients with Huntington\u2019s disease. N. Engl. J. Med. 380, 2307\u20132316 (2019).","journal-title":"N. Engl. J. Med."},{"key":"21934_CR20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3233\/JAD-131334","volume":"39","author":"D Alcolea","year":"2014","unstructured":"Alcolea, D. et al. Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer\u2019s disease: A multicenter study in Spain. J. Alzheimer\u2019s Dis. 39, 719\u2013726 (2014).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"21934_CR21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1212\/WNL.55.7.909","volume":"55","author":"RW Evans","year":"2000","unstructured":"Evans, R. W., Armon, C., Frohman, E. M. & Goodin, D. S. Assessment: Prevention of post\u2013lumbar puncture headaches. Neurology 55, 909\u2013914 (2000).","journal-title":"Neurology"},{"key":"21934_CR22","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/S0196-0644(05)80416-0","volume":"22","author":"RA Leibold","year":"1993","unstructured":"Leibold, R. A., Yealy, D. M., Coppola, M. & Cantees, K. K. Post-dural-puncture headache: Characteristics, management, and prevention. Ann. Emerg. Med. 22, 1863\u20131870 (1993).","journal-title":"Ann. Emerg. Med."},{"key":"21934_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1600-0404.1995.tb07029.x","volume":"91","author":"NJ Hindley","year":"1995","unstructured":"Hindley, N. J. et al. High acceptability and low morbidity of diagnostic lumbar puncture in elderly subjects of mixed cognitive status. Acta Neurol. Scand. 91, 405\u2013411 (1995).","journal-title":"Acta Neurol. Scand."},{"key":"21934_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-03938-3.50213-X","author":"DC Mayer","year":"2022","unstructured":"Mayer, D. C. & Spielman, F. J. Postdural Puncture Headache. Decis. Mak. Anesthesiol. https:\/\/doi.org\/10.1016\/B978-0-323-03938-3.50213-X (2022).","journal-title":"Decis. Mak. Anesthesiol."},{"key":"21934_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jamaneurol.2014.3974","volume":"72","author":"AE Monserrate","year":"2015","unstructured":"Monserrate, A. E. et al. Factors associated with the onset and persistence of post-lumbar puncture headache. JAMA Neurol. 72, 325\u2013332 (2015).","journal-title":"JAMA Neurol."},{"key":"21934_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/WAD.0000000000000209","volume":"31","author":"KL Moulder","year":"2017","unstructured":"Moulder, K. L. et al. factors influencing successful lumbar puncture in alzheimer research. Alzheimer Dis. Assoc. Disord. 31, 287\u2013294 (2017).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"21934_CR27","unstructured":"Roche & Genentech. Preliminary results from GENERATION HD1, a Phase III trial of tominersen in individuals with manifest HD - CHDI-2021-presentation-schobel-an-update-from-the-tominersen-global-clinical-development-programme.pdf. https:\/\/medically.gene.com\/global\/en\/unrestricted\/neuroscience\/CHDI-2021\/chdi-2021-presentation-schobel-an-update-from-the-tomin.html (2021)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21934-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21934-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21934-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:42:53Z","timestamp":1728261773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21934-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21934"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21934-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"22 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18377"}}